These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 21607722

  • 1. TDP-43 variants of frontotemporal lobar degeneration.
    Bigio EH.
    J Mol Neurosci; 2011 Nov; 45(3):390-401. PubMed ID: 21607722
    [Abstract] [Full Text] [Related]

  • 2. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S, Leigh PN, King A, Jones E, Steele JC, Bodi I, Shaw CE, Hortobagyi T, Al-Sarraj S.
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [Abstract] [Full Text] [Related]

  • 3. Laminar distribution of the pathological changes in sporadic frontotemporal lobar degeneration with transactive response (TAR) DNA-binding protein of 43 kDa (TDP-43) proteinopathy: a quantitative study using polynomial curve fitting.
    Armstrong RA, Hamilton RL, Mackenzie IR, Hedreen J, Cairns NJ.
    Neuropathol Appl Neurobiol; 2013 Jun; 39(4):335-47. PubMed ID: 22804696
    [Abstract] [Full Text] [Related]

  • 4. Annexin A11 aggregation in FTLD-TDP type C and related neurodegenerative disease proteinopathies.
    Robinson JL, Suh E, Xu Y, Hurtig HI, Elman L, McMillan CT, Irwin DJ, Porta S, Van Deerlin VM, Lee EB.
    Acta Neuropathol; 2024 Jun 19; 147(1):104. PubMed ID: 38896345
    [Abstract] [Full Text] [Related]

  • 5. Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.
    Mackenzie IR, Neumann M, Cairns NJ, Munoz DG, Isaacs AM.
    J Mol Neurosci; 2011 Nov 19; 45(3):402-8. PubMed ID: 21603977
    [Abstract] [Full Text] [Related]

  • 6. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M, Riascos D, Kovalik T, An J, Krupa K, Krupa K, Hood BL, Conrads TP, Renton AE, Traynor BJ, Bowser R.
    Acta Neuropathol; 2012 Nov 19; 124(5):717-32. PubMed ID: 22993125
    [Abstract] [Full Text] [Related]

  • 7. Frontotemporal lobar degeneration with ubiquitinated tau-negative inclusions and additional alpha-synuclein pathology but also unusual cerebellar ubiquitinated p62-positive, TDP-43-negative inclusions.
    King A, Al-Sarraj S, Shaw C.
    Neuropathology; 2009 Aug 19; 29(4):466-71. PubMed ID: 18715271
    [Abstract] [Full Text] [Related]

  • 8. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
    Armstrong RA, Carter D, Cairns NJ.
    Neuropathol Appl Neurobiol; 2012 Feb 19; 38(1):25-38. PubMed ID: 21696412
    [Abstract] [Full Text] [Related]

  • 9. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
    Tan RH, Yang Y, Kim WS, Dobson-Stone C, Kwok JB, Kiernan MC, Halliday GM.
    Acta Neuropathol Commun; 2017 Oct 27; 5(1):76. PubMed ID: 29078806
    [Abstract] [Full Text] [Related]

  • 10. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
    Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, Rogelj B, Al-Chalabi A, Hortobágyi T, Shaw CE.
    Acta Neuropathol; 2011 Dec 27; 122(6):691-702. PubMed ID: 22101323
    [Abstract] [Full Text] [Related]

  • 11. [Neuropathology of frontotemporal lobar degeneration with ubiquitinated inclusions].
    Yoshida M.
    Brain Nerve; 2009 Nov 27; 61(11):1308-18. PubMed ID: 19938688
    [Abstract] [Full Text] [Related]

  • 12. Heterogeneous ribonuclear protein E2 (hnRNP E2) is associated with TDP-43-immunoreactive neurites in Semantic Dementia but not with other TDP-43 pathological subtypes of Frontotemporal Lobar Degeneration.
    Davidson YS, Robinson AC, Flood L, Rollinson S, Benson BC, Asi YT, Richardson A, Jones M, Snowden JS, Pickering-Brown S, Lashley T, Mann DMA.
    Acta Neuropathol Commun; 2017 Jun 30; 5(1):54. PubMed ID: 28666471
    [Abstract] [Full Text] [Related]

  • 13. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.
    Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I, Smits V, Ceuterick-de Groote C, Van Broeckhoven C, Kumar-Singh S.
    Proc Natl Acad Sci U S A; 2010 Feb 23; 107(8):3858-63. PubMed ID: 20133711
    [Abstract] [Full Text] [Related]

  • 14. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF, Murray ME, Rutherford NJ, Castanedes-Casey M, DeJesus-Hernandez M, Liesinger AM, Baker MC, Boylan KB, Rademakers R, Dickson DW.
    Acta Neuropathol; 2013 Feb 23; 125(2):289-302. PubMed ID: 23053135
    [Abstract] [Full Text] [Related]

  • 15. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T.
    Neuropathology; 2018 Feb 23; 38(1):72-81. PubMed ID: 28960544
    [Abstract] [Full Text] [Related]

  • 16. A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation.
    Armstrong RA, Cairns NJ.
    Histol Histopathol; 2011 Feb 23; 26(2):185-90. PubMed ID: 21154232
    [Abstract] [Full Text] [Related]

  • 17. C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation.
    Josephs KA, Zhang YJ, Baker M, Rademakers R, Petrucelli L, Dickson DW.
    Acta Neuropathol Commun; 2019 Jul 02; 7(1):100. PubMed ID: 31266542
    [Abstract] [Full Text] [Related]

  • 18. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.
    Lashley T, Rohrer JD, Bandopadhyay R, Fry C, Ahmed Z, Isaacs AM, Brelstaff JH, Borroni B, Warren JD, Troakes C, King A, Al-Saraj S, Newcombe J, Quinn N, Ostergaard K, Schrøder HD, Bojsen-Møller M, Braendgaard H, Fox NC, Rossor MN, Lees AJ, Holton JL, Revesz T.
    Brain; 2011 Sep 02; 134(Pt 9):2548-64. PubMed ID: 21752791
    [Abstract] [Full Text] [Related]

  • 19. Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation.
    Bigio EH, Weintraub S, Rademakers R, Baker M, Ahmadian SS, Rademaker A, Weitner BB, Mao Q, Lee KH, Mishra M, Ganti RA, Mesulam MM.
    Neuropathology; 2013 Apr 02; 33(2):122-33. PubMed ID: 22702520
    [Abstract] [Full Text] [Related]

  • 20. ALS and FTLD: two faces of TDP-43 proteinopathy.
    Liscic RM, Grinberg LT, Zidar J, Gitcho MA, Cairns NJ.
    Eur J Neurol; 2008 Aug 02; 15(8):772-80. PubMed ID: 18684309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.